Missouri
Colorectal cancer clinical trials in Missouri
73 colorectal cancer studies are recruiting participants at sites in 23 cities across Missouri as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Missouri city with a recruiting study
St Louis (63), Kansas City (16), Springfield (16), Saint Joseph (10), Farmington (9), Sainte Genevieve (9), Sullivan (9), Columbia (8), Joplin (8), Ballwin (7), Cape Girardeau (7), Osage Beach (7), Rolla (7), Bolivar (6), Branson (6), Washington (6), Lee's Summit (4), Sunset Hills (4), City of Saint Peters (2), Creve Coeur (2), Liberty (2), Chesterfield (1), North Kansas City (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Missouri
Basic details from each study's public record (the 12 most recently updated of 73). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Recruiting in
- St Louis
- Registry record
- NCT06270706 · updated
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Kansas City
- Registry record
- NCT06997497 · updated
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- St Louis
- Registry record
- NCT07659795 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Recruiting in
- St Louis
- Registry record
- NCT07020221 · updated
The Vanguard Study: Testing a New Way to Screen for Cancer
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Kansas City · Springfield · St Louis
- Registry record
- NCT06995898 · updated
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- SWOG Cancer Research Network
- Recruiting in
- Ballwin · Bolivar · Branson · and 12 more U.S. locations
- Registry record
- NCT07018869 · updated
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
- Observational
- Ages 60 and older
- All sexes
- Sponsor
- Wake Forest University Health Sciences
- Recruiting in
- Cape Girardeau · Farmington · Saint Joseph · and 5 more U.S. locations
- Registry record
- NCT03998202 · updated
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Summit Therapeutics
- Recruiting in
- Springfield
- Registry record
- NCT07228832 · updated
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Oncolytics Biotech
- Recruiting in
- St Louis
- Registry record
- NCT07446322 · updated
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- EMD Serono Research & Development Institute, Inc.
- Recruiting in
- Columbia
- Registry record
- NCT07549412 · updated
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- No phase
- Ages 45 to 70
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Ballwin · Bolivar · Branson · and 9 more U.S. locations
- Registry record
- NCT05080673 · updated
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- Phase 2/3
- Ages 18 and older
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Ballwin · Bolivar · Branson · and 15 more U.S. locations
- Registry record
- NCT05174169 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Missouri on ClinicalTrials.gov.
Ask about studies in Missouri
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections